What is Jilin Aodong Pharmaceutical Group Co., Ltd.'s (000623.SZ) StockRank?

MoatMap's StockRank for Jilin Aodong Pharmaceutical Group Co., Ltd. (000623.SZ) is 69/100, with a Buy signal. This is a composite score combining Quality (54), Value (46), and Momentum (57) factor ranks across MoatMap's 19,000+ stock universe.

Does Jilin Aodong Pharmaceutical Group Co., Ltd. have an economic moat?

Jilin Aodong Pharmaceutical Group Co., Ltd. (000623.SZ) has a Quality factor score of 54/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the financial characteristics of a moated business.

Is Jilin Aodong Pharmaceutical Group Co., Ltd. a buy, hold, or sell?

MoatMap's current signal for Jilin Aodong Pharmaceutical Group Co., Ltd. (000623.SZ) is Buy, based on a StockRank of 69/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.

What sector is Jilin Aodong Pharmaceutical Group Co., Ltd. in?

Jilin Aodong Pharmaceutical Group Co., Ltd. (000623.SZ) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (China).

Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

000623.SZ

BUYREMOVE

Jilin Aodong Pharmaceutical Group Co., Ltd. · Healthcare · China · $3.0B · Avg Vol: $31M/d

StockRank

P/E (TTM)

7.6x

ROE

8.8%

D/E

0.1x

Dividend %

2.9%

Director Trades · 180d

None in 180d →

Buybacks · 180d

None in 180d →

AI CONVICTION THESIS

Jilin Aodong is a Chinese pharmaceutical company that also holds a large stake in GF Securities. This conglomerate structure lacks focus, transparency, and alignment with our high-conviction themes.

COMPANY DESCRIPTION

Jilin Aodong Pharmaceutical Group manufactures traditional Chinese medicines (TCM) and chemical pharmaceuticals while managing a highly valuable investment portfolio. The company's competitive moat is dual-layered, consisting of proprietary TCM formulations and a significant equity stake in GF Securities, which provides robust investment income. It operates as a unique hybrid of a pharmaceutical manufacturer and a financial holding company.

FINANCIAL SUMMARY

Year	2022	2023	2024	2025	CAGR
Revenue	424M	510M	386M	345M	-6.6%
EPS	0.23	0.19	0.19	0.30	9.2%
Shares	1.2B	1.2B	1.2B	1.2B	+2.8%
Debt	442M	448M	338M	331M	-9.2%
Equity	3.8B	4.0B	4.3B	4.5B	5.6%
Op CF	63M	10M	9M	40M	-13.7%
Inv CF	-82M	113M	65M	90M	—
Fin CF	-25M	-81M	-164M	-123M	—

PRICE (1M)-5.9%

SMA 50SMA 200

$2.64

RSI (14)

59.1

52W High

$3.26

From 52W High

0.8%

SCORE BREAKDOWN

Quality

ROIC

7.6%65.7

ROE

8.8%69.1

GP/Assets

3.0%15.7

Op. Margin

4.5%53.3

FCF/Assets

0.2%51.7

Piotroski

—55.8

Int. Cover

47.3x82.5

D/E Ratio

0.07x70.4

Current Ratio

2.38x44.1

Value

P/E (TTM)

7.6x93.1

EV/EBITDA

512.7x0.5

P/FCF

1825.0x4.3

P/B

0.7x87.5

P/S

9.5x27.2

Div Yield

2.9%67.6

Momentum

52W High %

81%75.9

RS 6M

-15%62.5

SMA 50/200

0.93x43.3

EPS Rev 4W

—N/A

EPS Rev 12W

—N/A

EPS Improve

-7%18.6

Q Growth

68%81.2

FUNDAMENTALS

Market Cap

$3.0B

P/E (Forward)

8.1x

Gross Margin

45.8%

SECTOR PEERS

Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of 000623.SZ are excluded.

Ticker	Company	Mkt Cap	StockRank	Signal
000623.SZ	Jilin Aodong Pharmaceutical Group Co., Ltd.(you)	$3.0B	69	BUY
300142.SZ	Walvax Biotechnology Co., Ltd.	$3.0B	67	BUY
002773.SZ	Chengdu Kanghong Pharmaceutical Group Co., Ltd	$2.9B	75	BUY
603858.SS	Shandong Buchang Pharmaceuticals Co., Ltd.	$2.3B	66	BUY
002399.SZ	Shenzhen Hepalink Pharmaceutical Group Co., Ltd.	$2.2B	67	BUY
002317.SZ	Guangdong Zhongsheng Pharmaceutical Co., Ltd.	$3.0B	60	HOLD
002262.SZ	Jiangsu Nhwa Pharmaceutical Co., LTD	$3.0B	79	BUY
301246.SZ	Hubei Hongyuan Pharmaceutical Technology Co., Ltd.	$1.9B	66	BUY
600085.SS	Beijing Tongrentang Co., Ltd	$5.2B	67	BUY
603707.SS	Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd.	$1.9B	65	BUY

Peer medians: ROE 4.7% · P/E 27.9x · Gross margin 53.1%

Jilin Aodong Pharmaceutical Group Co., Ltd. (000623.SZ) — Stock Score Summary

Jilin Aodong Pharmaceutical Group Co., Ltd. (000623.SZ) has a MoatMap StockRank of 69/100 based on Quality (54/100), Value (46/100), and Momentum (57/100) factor scores. The current signal is BUY. Jilin Aodong is a Chinese pharmaceutical company that also holds a large stake in GF Securities. This conglomerate structure lacks focus, transparency, and alignment with our high-conviction themes.

Key Financial Metrics

Price	$2.64
Market Cap	$3.0B
P/E (TTM)	7.58
P/E (Forward)	8.13
Price/Book	0.66
Return on Equity	8.8%
Return on Invested Capital	7.6%
Debt/Equity	7.09
Gross Margin	45.8%
Operating Margin	4.5%
Revenue Growth	-17.4%
Dividend Yield	2.9%
Free Cash Flow	$2M

Jilin Aodong Pharmaceutical Group Co., Ltd. operates in the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector (China).

Frequently Asked Questions

What is Jilin Aodong Pharmaceutical Group Co., Ltd.’s (000623.SZ) StockRank?: MoatMap’s StockRank for Jilin Aodong Pharmaceutical Group Co., Ltd. (000623.SZ) is 69/100, with a Buy signal. It is a composite of Quality (54), Value (46), and Momentum (57) factor ranks across MoatMap’s 19,000+ stock universe.
Does Jilin Aodong Pharmaceutical Group Co., Ltd. have an economic moat?: Jilin Aodong Pharmaceutical Group Co., Ltd. (000623.SZ) has a Quality factor score of 54/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Jilin Aodong Pharmaceutical Group Co., Ltd. a buy, hold, or sell?: MoatMap’s current signal for Jilin Aodong Pharmaceutical Group Co., Ltd. (000623.SZ) is Buy, based on a StockRank of 69/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Jilin Aodong Pharmaceutical Group Co., Ltd. in?: Jilin Aodong Pharmaceutical Group Co., Ltd. (000623.SZ) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (China).